Table 1.
Epitopes and variants studied
Epitope | ORF | CD4/CD8 | HLA | Variant | Frequency (%) | Countries | Global lineages | Loss of T cell response | References describing epitope |
---|---|---|---|---|---|---|---|---|---|
FTSDYYQLY207-215 | 3a | CD8 | A∗01:01 | Q213K | 0.059 | 56 | 95 | Yes | Ferretti et al. (2020); Kared et al., 2021; Peng et al. (2020); Schulien et al. (2021)a |
QRNAPRITF9-17 | N | CD8 | B∗27:05 | Q9H | 0.289 | 74 | 176 | No | Nelde et al. (2021); Peng et al. (2020) |
QRNAPRITF9-17 | P13L | 0.978 | 97 | 194 | Yes | Nelde et al. (2021); Peng et al. (2020) | |||
QRNAPRITF9-17 | P13S | 0.210 | 83 | 132 | Yes | Peng et al. (2020); Nelde et al. (2021) | |||
QRNAPRITF9-17 | P13T | 0.102 | 45 | 81 | Yes | Nelde et al. (2021); Peng et al. (2020) | |||
MEVTPSGTWL322-331 | N | CD8 | B∗40:01 | T325I | 0.069 | 52 | 109 | Partial | Nelde et al. (2021); Peng et al. (2020); Schulien et al. (2021)b |
KTFPPTEPK361-369 | N | CD8 | A∗03:01 A∗11:01 | T362I | 0.293 | 85 | 165 | Yes | Ferretti et al. (2020); Gangaev et al. (2020)b; Kared et al., 2021; Peng et al. (2020) |
KTFPPTEPK361-369 | T366I | 0.237 | 74 | 154 | No | Ferretti et al. (2020); Gangaev et al. (2020)b; Kared et al. (2021); Peng et al. (2020) | |||
KTFPPTEPK361-369 | P365S | 0.794 | 73 | 142 | Yes | Ferretti et al. (2020); Gangaev et al. (2020)b; Kared et al. (2021); Peng et al. (2020) | |||
KCYGVSPTK378-386 | S | CD8 | A∗03:01 | P384L | 0.085 | 59 | 116 | No | Ferretti et al. (2020); Peng et al. (2020) |
CTFEYVSQPFLMDLE166-180 | S | CD4 | – | L176F | 0.260 | 68 | 158 | No | Peng et al. (2020) |
CTFEYVSQPFLMDLE166-180 | M177I | 0.083 | 60 | 92 | Partial | Peng et al. (2020) | |||
NLLLQYGSFCTQLNR751-765 | S | CD4 | DRB1∗15:01 | R765L | 0.017 | 31 | 64 | Partial | Peng et al. (2020) |
0.000 | |||||||||
TTDPSFLGRY1637-1646 | ORF1A | CD8 | A∗01:01 | T1637I | 0.189 | 58 | 113 | Partial | Ferretti et al. (2020); Gangaev et al. (2020)b; Nelde et al. (2021) |
TTDPSFLGRY1637-1646 | T1638I | 0.066 | 52 | 96 | Partial | Ferretti et al. (2020); Gangaev et al. (2020)b; Nelde et al. (2021) | |||
TTDPSFLGRY1637-1646 | P1640S | 0.202 | 69 | 165 | Partial | Ferretti et al. (2020); Gangaev et al. (2020)b; Nelde et al. (2021) | |||
TTDPSFLGRY1637-1646 | P1640L | 2.540 | 105 | 156 | Partial | Ferretti et al. (2020); Gangaev et al. (2020)b; Nelde et al. (2021) | |||
TTDPSFLGRY1637-1646 | P1640H | 0.050 | 27 | 20 | Partial | Ferretti et al. (2020); Gangaev et al. (2020)b; Nelde et al. (2021) |
Mutated positions detailed in red within wild-type epitope sequence. Frequency indicates % of sequences where variant is seen within the SARS-CoV-2 mutation dataset downloaded from CoV-GLUE (http://cov-glue.cvr.gla.ac.uk/#/home) on July 30, 2021. Global Lineages refers to Pango lineage assignment.
ORF, open reading frame; HLA, human leukocyte antigen.
Responses to longer peptide also seen in Snyder et al. (2020).
Responses to longer peptide also seen in Snyder et al. (2020) and Kared et al. (2021).